Introduction
B. anthracis, the etiological agent of anthrax, is a zoonotic pathogen that can cause life threatening diseases in animals and humans. 1 Virulent strains of B. anthracis harbor two plasmids, pXO1 and pXO2, carrying unique genes that confer toxin production and capsule synthesis, respectively. [2] [3] [4] Due to its possible use as an agent for bioterrorism, B. anthracis is one of the most feared microorganisms.
The major challenge of developing a reliable assay for the detection of B. anthracis stems from its high similarity to other strains in its genus. B. anthracis is a member of the Bacillus cereus group of bacteria (B. cereus sensu lato) which comprises 6 genetically related species: B. cereus, B. anthracis, B. thuringiensis, B. mycoides, B. weihanstephanensis, and B. pseudomycoides. An extremely high degree of genomic homology exists between B. cereus, B. anthracis, and B. thuringiensis, which some authors consider genetically just one species. 5, 6 The main difference between these species is the presence of unique virulence plasmids. However, data gathered in the last decade have shown that B. cereus strains that contain anthrax-specific pXO-like plasmids exist [7] [8] [9] [10] [11] [12] which further obscure the much intermixed phylogenetic structure of the B. cereus group.
Some PCR-based assays in use for detection of B. anthracis rely on plasmid-encoded targets in conjunction with a chromosomal marker to correctly differentiate pathogenic from apathogenic B. anthracis strains and B. anthracis from non-anthracis Bacillus species, respectively (for a review see ref. 13 ). The importance of including a chromosomal assay to verify the presence of B. anthracis independently of plasmid occurrence was emphasized by the discovery of forms of B. anthracis isolates lacking plasmids, B. cereus isolates harboring anthrax-like virulence plasmids, and pXO2 gene homologs in environmental Bacillus isolates. [7] [8] [9] [10] [11] [12] Several chromosomal targets have been investigated for identification purposes, but most of the markers reported to be unique for B. anthracis were in fact common to both B. anthracis and a subpopulation of closely related B. cereus and B. thuringiensis strains. [13] [14] [15] Few chromosomal sequences that provide sufficient polymorphism to unambiguously distinguish B. anthracis from its near neighbors have been identified. 14, [16] [17] [18] [19] [20] [21] [22] Some of these assays rely upon single-nucleotide differences for discrimination and are therefore sensitive to assay conditions and PCR cycling parameters. Small alterations in these conditions can result in the loss of specificity, especially with hydrolysis probes, i.e., TaqMan chemistry. 18, [23] [24] [25] To evaluate the wide range of PCR methods used in laboratories for B. anthracis identification, a computer-based comparative analysis of more than 300 PCR-target sequences reported in the literature was conducted. All sequences were compared against all publicly available Bacillus genomes and sorted for specificity. The three assays with highest in silico specificity, together with three assays with lower specificity, were evaluated in an international ring trial using DNA of Bacillus strains exchanged in the framework of the EU AniBioThreat project. The best chromosomal signatures for reliable B. anthracis genome detection are discussed for the purpose of selecting an assay as international standard for B. anthracis detection.
Results

Literature survey of PCR-based detection methods
The literature survey showed that at least 20 different chromosomal markers have been described ( Table 1) . [13] [14] [15] The first DNA signatures that were developed for anthrax PCR detection methods independently of plasmids occurrence were DNA fragments used to genotype B. anthracis. They include the vrrA marker, [26] [27] [28] the AC-390 gene, 29 and the SG-850/749 fragment. 30 These genetic markers provide limited specificity and require additional timeconsuming and labor-intensive post-PCR analysis steps. Other areas of the chromosome have also been investigated as potential DNA-targets for identification purposes, including the so-called BA813 [31] [32] [33] [34] [35] [36] [37] [38] and BA5510 sequences, 19 genes bclB, 39 sap, 40, 41 saspB, 5, 42 and sspE, 22, 43 the B-type small acid-soluble spore protein gene (SASP), 44 a glycosyltransferase group 1 family protein, 45 a protein showing similarities with an abhydrolase, 18 and several DNA loci located on prophage regions, 17 i.e., BA5345, 21 BA5357, 46 and PL3. 47 Although most of these regions have been claimed to be anthrax-specific, B. cereus strains sometimes yield false-positive results. [13] [14] [15] Finally, a few single nucleotide polymorphisms (SNP) have also been considered for PCR markers. Target genes include rpoB, 24, [48] [49] [50] [51] gyrA, 25, 52, 53 gyrB, 54, 55 plc, 20, 23, 53, 56 purA, 57 and the 16S-23S rDNA internal spacer sequences. [58] [59] [60] But, so far, only the nonsense mutation in the global regulator PlcR, which controls the transcription of secreted virulence factors in B. cereus and B. thuringiensis, have proved to be truly unique to B. anthracis strains. 16, 20, 59 False-positive signals have sometimes been recorded with closely related strains of the B. cereus group using the other published SNPs. 24, 49, 52, 59, [61] [62] [63] In silico analysis About a hundred sequences corresponding to all primers and probes currently published were compiled and compared using the primer alignment function of the Gegenees software (www. gegenees.org). 64 Each sequence was tested against all available Bacillus spp. genomes and scored for specificity ( Table 1) . Bacillus is one of the largest genera represented in the bacterial genome database, with about 140 distinct members of the B. cereus group sequenced (www.ncbi.nlm.nih.gov).
Excluding SNP discrimination assays, it was found that out of the 35 PCR assays analyzed in silico, only four were specific for the B. anthracis chromosome, with a minimum unalignment value for background genomes higher than zero ( Table 1) . These assays target the markers BA5345, 21, 65 PL3, 47 and BA5357, 46 respectively. Three of these assays are based on hydrolysis probe ("TaqMan assay"); the fourth uses SYBR Green chemistry. These primer/probe sequences showed a perfect match to all B. anthracis genomes, and very poor matches to B. thuringiensis and B. cereus strains, including strains that are known to be phylogenetically very closely linked to B. anthracis. All other assays were found to be prone to false positive identification, as perfect matches were found for several B. cereus and B. thuringiensis strains.
To illustrate the complexity of the B. cereus group and why PCR-markers cross-react with some B. cereus and B. thuringiensis strains, we compared the genomes of 22 strains that were later used for PCR assays assessment in the ring trial (see below). Table 2 shows a similarity matrix that gives a phylogenomic overview of the 22 genomes. We considered an 80% average core genome similarity as threshold for a strain to be called a near neighbor as genomes passing this criterion produced most cross-reactions. Assessment of several in silico primer alignments showed that the vast majority of the cross reactions occurred within the nearneighbor group, at least for the better performing assays.
Regarding assays relying upon single-nucleotide differences for discrimination, the in silico investigation confirmed that the plcR and purA point mutations were unique to B. anthracis strains (data not shown). The SNP at position 1668 of gyrA was also found to be a relatively specific marker for B. anthracis identification as only one genome (B. thuringiensis serovar monterrey BGSC 4AJ1) contained the C variant specific for B. anthracis. Screening other published SNPs resulted in false-positive signals for several strains of the B. cereus group (data not shown). ND, BLasT could not handle Y, W and R; s, probe; p, primer; np, nested primer; hP, hydrolysis probes; MGB, minor-grove-binding; FReT, hybridization probes; RaPD, random amplification of polymorphic DNa; LNa, locked nucleic-acid; GT, glycosyltransferase. *DNa located on prophage region.
Ring trial
The three hydrolysis probe assays with highest specificities in the in silico analysis (BA5345, PL3, and BA5357) were evaluated in vitro using a panel of 90 Bacillus strains in a laboratory ring-trial performed at 5 European laboratories (RIVM, DTU, SVA, ANSES, and CVI). Assays mentioned by the World Health Organization (WHO) 31, 40, 44 were also included in the ring trial, as well as a hydrolysis probe assay 35 that targets the often used BA813 marker [31] [32] [33] [34] [35] [36] [37] [38] (Table 3 ). The latter marker has shown in silico cross-reactions toward the near-neighbor strains in use in this trial and was included for this reason. The two WHO procedures tested are, respectively, a formerly used conventional gel-based PCR assay targeting the S-layer gene sap 40 and a dual hybridization probes qPCR assay targeting a gene encoding the small acid-soluble spore protein SASP. 44 Results of the ring trial confirmed the results obtained in the in silico analysis ( Table 4) . The three assays with highest in silico specificity (BA5345, 21 PL3, 47 and BA5357 46 ) all performed well in the ring trial, with diagnostic sensitivity and specificity values close to 1 ( Table 5) . Furthermore, these assays were found to be robust and provided consistent results between laboratories (kappa values of 0.9-1.0). All 31 B. anthracis strains were correctly detected, except in one laboratory that failed to detect one sample with a lower DNA content using the BA5345 assay. None of the non-anthrax strains gave false-positive results for these assays for any of the participating laboratories.
The results obtained using the S-layer, 40 BA813, 35 and SASP 44 assays displayed a lower agreement among laboratories (k values of 0.5-0.8). In general, the three methods had relative low diagnostic sensitivity and specificity compared with the BA5345, PL3, and BA5357 assays, indicating that these methods have a lower performance both in detecting B. anthracis in truly contaminated samples and in declaring truly non-contaminated samples as free of B. anthracis. Although the BA813 assay was found to be quite effective in identifying true B. anthracis strains-except for laboratory 2, which failed to detect two strains-it yielded a number of false-positive results (ranging from 11 to 23 strains) in all laboratories. As for the former WHO recommended S-layer assay, 40 this conventional PCR method was apparently not as sensitive as several of the others (Table 5) , producing false-negative results in 6 Virulence Volume 4 Issue 8 Table 2 . similarity matrix created by Gegenees over a set of 22 Bacillus strains used in this study. all laboratories. In contrast, higher specificity (specificity ranging from 0.88 to 0.95, depending on laboratory, Table 5 ) was obtained with the current WHO recommended SASP assay. 44 This assay correctly identified most of the closely related strains, even though improper but late amplifications were sporadically observed for a few strains (ranging from 3 to 5). All B. anthracis strains were tested PCR-positive by two of the three laboratories that had succeeded to implement the assay on their PCR platforms. The WHO protocol relies on fluorescence resonance energy transfer (FRET) probes chemistry, but not all real-time PCR instruments have detection systems including a channel designated for FRET experiments. The third laboratory equipped with FRET-capabilities failed to detect five samples with lower DNA concentration ( Table 4) .
Limit of detection of the PL3 assay
In order to propose a single reference method for B. anthracis chromosome detection to diagnostic laboratories throughout Europe, we further assessed the laboratory sensitivity of one of the best performing assays identified in this work, the PL3 assay. 47 Serial dilutions of genomic DNA from B. anthracis strain 17JB were tested to determine the lowest concentration of DNA that could be detected at 95% probability. The detection limit (LOD PCR at 95% confidence interval) was found to be 2 genome equivalents. Performance in artificially contaminated organs (wild boar spleen) was also examined using 10-fold dilutions of calibrated suspensions of vegetative cells. Non-inoculated samples were confirmed to be negative. A reproducible detection (100%, n = 9) of samples containing 11 vegetative cells/PCR was observed, corresponding to 10 3 B. anthracis CFU per ml of spleen homogenates. Samples containing fewer targets (i.e., 10 2 CFU/ ml) could be sporadically detected (data not shown).
Discussion
PCR-based identification assays are fast and sensitive methods, widely used in food, clinical or veterinary laboratories to detect the presence of pathogens or to confirm species identity. Reliable detection requires the selection of primers and probes that hybridize efficiently and specifically with DNA from the targeted bacterium, in order to prevent false negative or false-positive results. For the almost clonal species of B. anthracis, the selection of robust DNA signature sequences for the development of PCR assays has proven to be a very difficult task since few of the investigated markers proved to be truly unique for the species. At present, only three chromosomal features appeared to be useful to differentiate B. anthracis from the rest of the B. cereus group at the genetic level: (1) being part of the clonal cluster made up of highly monomorphic B. anthracis strains, as analyzed by MLST, MLVA or similar methods; (2) carrying a nonsense mutation at nucleotide position 640 of the plcR gene, introducing a premature TAA stop codon; and (3) presence of a unique combination of four excision-proficient, lambdoid prophages (lambda01-04). 4, 16, 66 An unexpectedly high amount of PCR assays (~88 %) were found to be unspecific for B. anthracis. This is mostly because not much was known about the genetically closely related strains until the recent rapid increase in available genome sequences. The increasing use of Next Generation Sequencing technologies in systematic characterization of bacterial genomes has offered a powerful approach for large-scale genome comparisons and identification of specific DNA signatures. This is illustrated by the current study in which a thorough in silico analysis of published PCR assays for the detection of B. anthracis was possible due to the availability of manifold genome sequences. Conclusions drawn from this in silico analysis of the full set of Bacillus spp. genomes published to date were the following:
1) There was no PCR assay with superior specificity for any common target carried by the pXO1 or pXO2 virulence plasmids (lef, cya, pag, and cap), since several B. cereus strains were found to contain pXO-like plasmids carrying highly similar genes (data not shown), as was previously reported by others. [7] [8] [9] [10] [11] [12] 2) Only two single-nucleotide differences appeared to be reliable markers for the specific identification of B. anthracis: a variant at nucleotide position 640 in the plcR gene or at position 1050 in the purA gene.
3) The four highly specific assays identified in silico (i.e., Antwerpen, Lewerin, Létant, and Wielinga) target three different loci located within the lambdaBa03 prophage region (ranging from BA5339 to BA5363 loci in the Ames annotated genome). All other markers that had been thought to discriminate B. anthracis from other B. cereus group bacteria were found in at least some closely related strains and could therefore result in erroneous species attribution, as exemplified by the BA813-targeted assays or the S-layer assay. 40 Except for the recent SASP assay, 44 most of the published assays gave poor results in the in silico analysis ( Table 1) , including those referred to in the Terrestrial Manual of OIE, 67 i.e., Jackson et al. 27 and Ramisse et al. 31 However, to our knowledge, this is the first study addressing the in vitro evaluation of the SASP genomic markers. Our results should be confirmed on a larger panel of Bacillus strains to enable clear conclusions. Nevertheless, when standardizing PCR based detection methods for B. anthracis, the latter assay might be problematic with regard to its ease of implementation. The WHO protocol is based on a hybridization probes format for DNA detection and quantification by real-time PCR, and only a part of the qPCR instruments on the market currently includes detection system with decoupled excitation and emission filter channels that allow the use of hybridization probes (FRET) chemistry. 68 Hydrolysis probes are more commonly applied and thus form an alternative that should be more universally applicable.
Although excision proficient prophage sequences are generally not considered useful targets for bacterial identification because of their instability, the persistent presence of the four prophage regions in all B. anthracis genomes can be advantageously utilized for the definitive discrimination of B. anthracis from other B. cereus group bacteria. 66 Given the high impact of the anthrax identification issue, one must be cautious and avoid relying solely on assays based on SNP discrimination. Such assays are more sensitive to assay conditions compared with assays relying on unique 53 ), they are neither as robust nor as user friendly as assays based on unique signature sequences. The chromosomal markers BA5345 (Antwerpen), PL3 (Wielinga), or BA5357 (Letant), enable unambiguous identification of B. anthracis strains, including plasmid-cured isolates. Moreover, the PL3 assay was confirmed to be sensitive enough to be used in biological samples. High diagnostic sensitivity of the assay reduces the occurrence of false-negative results, which can be further reduced by the use of an internal control to prevent pipetting errors. It should be emphasized that one of these assays should be implemented in conjunction with plasmid-encoded targets in B. anthracis-specific PCR methods to discriminate non-virulent from virulent strains.
In conclusion, this study highlights the importance of analyzing the diagnostic sensitivity and specificity of PCR assays designed for detection of B. anthracis, as many of particularly the older protocols produce both false negative and false-positive results. This is important with regard to the aim of standardization of a PCR assay for B. anthracis detection. Even though only slight differences regarding the analytical sensitivity were observed between the three highly specific chromosomal assays during the ring-trial, we propose the robust and sensitive PL3 assay as possible European standard to harmonize and improve PCR methods for detection of anthrax in animal, feed, environmental, and food samples based on results of this study.
Materials and Methods
Strains
DNA from a total of 90 Bacillus strains were used in this study, including 31 B. anthracis isolates, 44 strains of B. cereus or B. thuringiensis, and 15 strains encompassing 10 other bacterial species ( Table 4) . Strains came from the collections of Bacilli of the different partners: Anses (n = 27), SVA (n = 22), CVI (n = 9) and RIVM (n = 32). Of the 90 B. cereus group strains used for in vitro studies, 22 had publicly available whole genome sequences ( Table 2) , including 11 B. cereus or B. thuringiensis strains closely related to B. anthracis ( Table 2 ) and reported as near-neighbors based on multilocus sequence typing analysis. 16 All DNA samples were randomly coded and sent to each of the 5 participating laboratories.
DNA extraction procedures At Anses, B. anthracis suspensions were incubated at 100 °C in boiling water for 20 min. After cooling and centrifugation, viability testing was performed to verify absence of live B. anthracis. DNA from artificially contaminated samples was further purified using the High Pure PCR template Preparation Kit from Roche according to the manufacturer's recommendations. DNA from non-pathogenic non-B. anthracis bacilli cultures was alternatively extracted using a 200 μl aliquot of InstaGeneTM Matrix as described by the supplier (Bio-Rad Laboratories).
At CVI, bacterial suspensions were inactivated at 100 °C for 10 min and tested for absence of viable B. anthracis by plating aliquots on nutrient agar petri dishes. DNA was purified using the QIAamp DNA Mini Kit (Qiagen Benelux).
At RIVM, bacteria suspensions were incubated at 100 °C for 30 min, centrifuged at maximum speed for 1 min and the resulting lysates were transferred to a 0.22 μm sterile Ultrafree-MC spin filter (Millipore). The spin filter was then centrifuged for 4 min at maximum speed to clean the DNA lysate from left over cell debris. DNA lysates from B. anthracis and non-pathogenic bacteria were further purified or isolated, respectively using the NucliSENS Magnetic Extraction reagents (bioMerieux) following the manufacturer instructions.
At SVA, bacterial cultures were centrifuged and DNA extracted from the pellet using the MasterPure Gram positive kit (Epicenter Biotechnologies). The DNA was taken out of the BSL-3 facility by first passing it through an Ultrafree-MC 0.22 μm sterile filter (Merck Millipore).
Internal amplification control A fragment of the blue fluorescent protein gene (bfp) was used as an internal amplification control (IAC). The IAC primers and probe were designed such that they do not interact with any of the primers and probes from the tested assays. Oligonucleotides design was performed by using the software package Visual Oligonucleotide Modeling Platform version 6 (DNA Software Inc.). The primers and probe were the following: ABbfp_F (5′-TCATGGCCGA CAAGCAGAA-3′), ABbfp_R (5′-GCTCAGGGCG GACTG-3′), and ABbfp_Tq (5′-Cy5-CGACCACTAC CAGCAGAACA CC-BHQ2-3′). Amplicons from the bfp gene were produced by using conventional PCR and were purified by using the Qiagen PCR purification kit. The amount of amplicons that need to be added to samples to obtain suitable Cq values for use as internal control was determined empirically from 10-fold serial dilutions. The developed real-time qPCR assays were used to determine the amplicon dilution needed for a Cq value between 32 and 35.
Conventional and real-time qPCR conditions
Participating laboratories were asked to investigate the complete set of blinded samples using the PCR platforms available at their institute. Real-time qPCR and conventional thermocyclers used were the following: Mx3005p (Stratagene); ABI 7500 Fast, StepOnePlus or AB9700 (Applied BioSystems); LightCycler 2.0 or LightCycler 480 (Roche Applied Science); C1000, iCycler or MyCycler (BioRad). Primers and probes were synthesized by each laboratory's usual suppliers (Eurogentec, Metabion, Sigma or Eurofins MWG operon). Total PCR reaction volume (20 μl) and template volume (2 μl of Bacillus DNA and 2 μl of the IAC DNA) were kept constant. Each laboratory also used the same qPCR kits and DNA polymerases as in their routine diagnostic activities. Table 3 ). In silico analysis Gegenees (http://www.gegenees.org) is open software that uses a fragmented alignment approach for the comparative analysis of hundreds of microbial genomes. 64 The genomes are fragmented and compared, all against all, by a multithreaded BLAST control engine. Each data point connecting two genomes is represented by a score. Although this genome alignment and data mining is the main application of Gegenees, it is also equipped with a primer alignment function that facilitates the alignment of several primers against a large amount of genomes for specificity testing.
The FTP-function of Gegenees was used to download all the available Bacillus spp. genomes from NCBI Genomes which, at the time of the study, amounted to 134 genomes. All primer/ probe sequences from the literature survey were aligned to the 134 genomes with a short-sequence-setting (i.e., word length of 7) for the BLAST+ algorithm and the alignments were then sorted according to their "unalignment index". The unalignment index is the sum of non-aligned nucleotides and reported mismatches. A minimal unalignment index value of 0 for a primer corresponds to perfect sequence match with the genome the primer aligned to. Results have been acquired for all published sequences, regardless of the kind of assay reported (e.g., real-time qPCR, conventional PCR, LAMP, microarray, etc.) or targets used (pXO1-, pXO2-plasmid, or chromosomal DNA). Only data from chromosomal markers (n = 35) are reported in the present study ( Table 1) .
To illustrate the relatedness of the B. cereus group strains used in this study to B. anthracis, a whole genome comparison of the 22 available sequenced whole genome genomes was also performed ( Table 2) . Gegenees was set to perform an all-all fragmented alignment using 500 bp fragments. The average genomic core genome similarity values were also calculated ( Table 2) .
Ring trial A ring trial was performed among 5 European laboratories in the framework of the EU AniBioThreat project (http://www. anibiothreat.com). Six published PCR-assays targeting different B. anthracis chromosomal markers were evaluated in vitro. The most specific methods according to in silico analysis 21, 46, 47 were compared with the assays recommended by the WHO 40, 44 and a single assay targeting BA813. 35 Ninety blinded DNA samples were exchanged between partners and an IAC was distributed. A detailed standard operative protocol describing how to conduct and perform the ring trial was set up after consultation of all participating laboratories. Samples were re-tested in case of IAC inhibition. A reporting form file was distributed among participants to record the results.
Diagnostic sensitivity and specificity for all assays and laboratories were calculated together with the kappa values in SAS 9.1.3 (SAS Institute Inc.) using the FREQ procedure. The sensitivity was defined as the fraction of positive DNA samples which were known to contain B. anthracis (as determined by standard methods used by the different culture collections) that gave a positive PCR results by the different methods. Specificity was defined as the fraction of negative DNA samples which were known not to contain B. anthracis DNA that gave a negative PCR results by the different PCR methods. Kappa values measure the level of agreement between results obtained by the different participating laboratories and PCR methods combinations. The calculation is based on the difference between how much agreement is actually present ("observed" agreement) compared with how much agreement would be expected to be present by chance alone ("expected" agreement). A kappa value of 1 indicates perfect agreement, whereas a kappa of 0.5 indicates moderate agreement and a value of 0 indicates that the apparent agreement is only due to chance.
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Detection limit of the PL3 assay The limit of detection of the PL3 assay 47 was determined by using serial dilutions of genomic DNA from B. anthracis strain 17JB. Six dilutions around the expected limit of detection (corresponding to 5, 2, 1, 0.5, 0.2, and 0.1 genome equivalents) were used to calculate a precise LOD PCR value (3 runs, 24 replicates for each dilution). 70 Genomic DNA was quantified by fluorimetry using the Qubit® 2.0 Fluorometer (Invitrogen). The number of genomic copies was calculated as follows: m = n × (1.013 × 10 -21 g/bp), where m is the mass and n is the number of base pairs.
Wild boar spleen homogenates were used to assess the sensitivity of the assay in biological samples. Portions of 1 ml were artificially inoculated in triplicate at five contamination levels with calibrate suspensions of vegetative cells (ranging from 5.5 × 10 1 to 5.5 × 10 5 CFU/ml) from strain 17JB as previously described. 53 Samples were then incubated at 56 °C for 1 h in the presence of proteinase K and inactivated for 20 min at 100 °C in boiling water. After cooling and centrifugation, viability testing was performed to verify depletion of live B. anthracis. DNA was then extracted from 200 μl aliquots using the High Pure PCR Template Preparation Kit (Roche). Two microliter aliquots of the eluted DNA were used as template. The exact numbers of cells introduced into spleen homogenates were determined a posteriori by plating.
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